| Primary |
| Product Used For Unknown Indication |
15.9% |
| Drug Use For Unknown Indication |
13.6% |
| Migraine |
12.9% |
| Headache |
10.6% |
| Pain |
5.3% |
| Myoclonic Epilepsy |
4.5% |
| Osteoarthritis |
4.5% |
| Pyrexia |
4.5% |
| Depression |
3.8% |
| Sepsis |
3.8% |
| Overdose |
3.0% |
| Bipolar Disorder |
2.3% |
| Device Related Infection |
2.3% |
| Epilepsy |
2.3% |
| Hypertension |
2.3% |
| Insomnia |
2.3% |
| Agoraphobia |
1.5% |
| Alcohol Use |
1.5% |
| Analgesia |
1.5% |
| Attention Deficit/hyperactivity Disorder |
1.5% |
|
| Death |
70.2% |
| Cardio-respiratory Arrest |
11.1% |
| Inhibitory Drug Interaction |
2.0% |
| Hepatotoxicity |
1.5% |
| Nausea |
1.5% |
| Pyroglutamate Increased |
1.5% |
| Acute Hepatic Failure |
1.0% |
| Diarrhoea |
1.0% |
| Drug Interaction |
1.0% |
| Hallucination, Auditory |
1.0% |
| Intentional Overdose |
1.0% |
| Potentiating Drug Interaction |
1.0% |
| Somnolence |
1.0% |
| Stomatitis |
1.0% |
| Tic |
1.0% |
| Whiplash Injury |
1.0% |
| Abdominal Discomfort |
0.5% |
| Abdominal Pain |
0.5% |
| Abdominal Pain Upper |
0.5% |
| Agitation |
0.5% |
|
| Secondary |
| Foetal Exposure During Pregnancy |
14.6% |
| Headache |
14.6% |
| Migraine |
12.9% |
| Product Used For Unknown Indication |
12.7% |
| Pain |
9.7% |
| Drug Use For Unknown Indication |
6.6% |
| Depression |
4.1% |
| Hypertension |
4.1% |
| Multiple Sclerosis |
3.9% |
| Anxiety |
2.5% |
| Insomnia |
2.3% |
| Bipolar Disorder |
2.1% |
| Mental Status Changes |
1.6% |
| Back Pain |
1.4% |
| Clostridial Infection |
1.2% |
| Drug Dependence |
1.2% |
| Nausea |
1.2% |
| Nervousness |
1.2% |
| Agoraphobia |
1.0% |
| Asthma |
1.0% |
|
| Death |
28.7% |
| Drug Hypersensitivity |
6.4% |
| Vomiting |
6.4% |
| Weight Decreased |
6.4% |
| Cardio-respiratory Arrest |
5.3% |
| Drug Ineffective |
5.3% |
| Pyrexia |
5.3% |
| Migraine |
4.3% |
| Tic |
4.3% |
| Headache |
3.2% |
| Osteoporosis |
3.2% |
| Overdose |
3.2% |
| Tongue Paralysis |
3.2% |
| Depression |
2.1% |
| Drug Exposure During Pregnancy |
2.1% |
| Drug Screen Negative |
2.1% |
| Liposarcoma |
2.1% |
| Mental Status Changes |
2.1% |
| Pain |
2.1% |
| Partial Seizures |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.0% |
| Migraine |
10.7% |
| Drug Use For Unknown Indication |
10.1% |
| Pain |
8.4% |
| Headache |
7.5% |
| Depression |
6.2% |
| Hypertension |
4.2% |
| Gastrooesophageal Reflux Disease |
3.5% |
| Anxiety |
3.4% |
| Multiple Sclerosis |
3.1% |
| Contraception |
2.8% |
| Nausea |
2.8% |
| Insomnia |
2.3% |
| Rheumatoid Arthritis |
2.3% |
| Fibromyalgia |
1.9% |
| Asthma |
1.9% |
| Sleep Disorder |
1.9% |
| Blood Cholesterol Increased |
1.8% |
| Crohn's Disease |
1.8% |
| Back Pain |
1.5% |
|
| Vomiting |
14.2% |
| Weight Increased |
9.8% |
| Weight Decreased |
9.4% |
| Pain |
8.8% |
| Pulmonary Embolism |
5.9% |
| Headache |
4.9% |
| Drug Ineffective |
4.6% |
| Urinary Tract Infection |
4.5% |
| Nausea |
4.2% |
| Pain In Extremity |
4.2% |
| Wrong Technique In Drug Usage Process |
3.9% |
| Vision Blurred |
3.7% |
| Dyspnoea |
3.0% |
| Suicidal Ideation |
3.0% |
| Gallbladder Disorder |
2.9% |
| Migraine |
2.9% |
| Withdrawal Syndrome |
2.7% |
| Pyrexia |
2.6% |
| Cerebrovascular Accident |
2.4% |
| Hypothyroidism |
2.4% |
|
